New sensor options for smart fracture implants and wearable devices: Laser-Doppler and white-light spectroscopy allow monitoring of bone regeneration via perfusion measurement
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117442 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Oana Scholz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Implant Development (Fracture Healing), Departments and Institutes of Surgery, Saarland University, Homburg, Germany. Hauptthemen laut MEDLINE: Biosensing Techniques, Wearable Electronic Devices, Fracture Healing, Spectrum Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Werner Siemens Foundation.
Abstract (Originalsprache)
The diagnostic options for monitoring fracture healing are currently limited to methods that expose patients to ionizing radiation, i.e. X-rays or computed tomography. The development of new methods that ideally allow continuous monitoring via smart implants or wearables is urgently needed. Laser-Doppler and white-light spectroscopy, non-invasive light-based methods, could allow to monitor fracture healing via changes in perfusion, but this has never been investigated. It was hypothesized that 1) blood flow (BF) increases before a linear increase in oxygen saturation (SO2) and that 2) SO2 in nonunion cases remains as low as the minimum in union cases. A longitudinal observational cohort study with tibial fracture patients was conducted with additional cross-sectional measurements in nonunion patients and healthy controls. To assess SO2, relative haemoglobin amount (rHb), and BF in the fracture gap, the 'Oxygen to see' (O2C) device was used. Thirty-five patients (20 longitudinal, 15 nonunion) and 28 controls were included. In the longitudinal group, SO2 decreased, reaching a minimum (10 mm: 17.96 days, 16 mm: 15.50 days), and subsequently increased. BF increased to a maximum (10 mm: 12.90 days, 16 mm: 33.51 days), followed by a decrease. The SO2 values in the nonunion group were similar to the minimum values in the longitudinal group. Findings in nonunion patients vs. controls differed only in SO2 (10 mm: p < 0.001, 16 mm: p = 0.038), not in rHb or BF. Laser-Doppler and white-light spectroscopy provide characteristic SO2 and BF trajectories that may serve to monitor fracture healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovative Implant Development (Fracture Healing), Departments and Institutes of Surgery, Saarland University, Homburg, Germany.
- Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
- Innovative Implant Development (Fracture Healing), Departments and Institutes of Surgery, Saarland University, Homburg, Germany; Department of Trauma, Hand and Reconstructive Surgery, Departments and Institutes of Surge…
Förderung
- Werner Siemens Foundation
Zitieren
APA
Scholz, O., Nowicki, C., Warmerdam, E., Rother, S., & Ganse, B. (2025). New sensor options for smart fracture implants and wearable devices: Laser-Doppler and white-light spectroscopy allow monitoring of bone regeneration via perfusion measurement. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117442
Vancouver
Scholz O, Nowicki C, Warmerdam E, Rother S, Ganse B. New sensor options for smart fracture implants and wearable devices: Laser-Doppler and white-light spectroscopy allow monitoring of bone regeneration via perfusion measurement. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117442
BibTeX
@article{Scholz2025,
author = {Scholz, Oana and Nowicki, Cedric and Warmerdam, Elke and Rother, Sandra and Ganse, Bergita},
title = {New sensor options for smart fracture implants and wearable devices: Laser-Doppler and white-light spectroscopy allow monitoring of bone regeneration via perfusion measurement},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117442}
}
EUVIMED